GlassScriptPhysician profile
Matthew S Sanzalone
NPI 1467834820
$3,560.51
in general payments reported to CMS, 2019-2025
19 companies · $239 in 2025
The $239 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,998 · 2020: $16.92 · 2021: $160 · 2022: $309 · 2023: $347 · 2024: $491 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,077.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,076.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,378.69 | 2019-2025 | Eterna, Proclaim |
| Boston Scientific Corporation | $895.10 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $315.36 | 2022-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Abbvie INC. | $233.86 | 2022-2025 | Botox |
| Collegium Pharmaceutical, INC. | $121.36 | 2021-2025 | Xtampza, Belbuca |
| Avanos Medical | $107.34 | 2024-2025 | Coolief* Cooled Radiofrequency, Coolief Cooled Radiofrequency |
| Pfizer INC. | $82.86 | 2023-2025 | |
| Allergan, INC. | $82.43 | 2021-2022 | |
| Valinor Pharma, LLC | $53.68 | 2023 | Movantik |
| Nevro Corp. | $53.60 | 2020-2021 | |
| Protega Pharmaceutials INC | $43.25 | 2024-2025 | Roxybond |
| Biotronik Nro, INC. | $40.79 | 2023-2024 | Biotronik, Prospera |
| Biohaven Pharmaceutical Holding Company LTD. | $36.08 | 2022 | |
| Axsome Therapeutics, INC. | $25.84 | 2025 | Symbravo |
| Stimwave Technologies Incorporated | $22.39 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Painteq LLC | $19.89 | 2024 | Painteq |
| Saluda Medical Americas, INC. | $19.15 | 2024 | Evoke |
| Vertos Medical, INC. | $15.05 | 2021 | |
| Spr Therapeutics, INC | $13.79 | 2023 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Sanzalone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.